Join Caroline Behler, MD, as she reviews data from 2 pivotal trials assessing Adcetris+AVD vs ABVD in previously untreated Stage III/IV classical Hodgkin lymphoma (cHL), and Adcetris+CHP vs CHOP in previously untreated CD30-expressing peripheral T-cell lymphomas (PTCL).
Join Babis Andreadis, MD, UC San Francisco, Brian A. Jonas, MD, PhD, UC Davis, and Michaela Liedtke, MD, Stanford University as they present the latest treatment modalities for hematologic malignancies. Alfred Chung, MD, Stanford University will then present cases for discussion illustrating the new treatment modalities.
On July 1, 2017, California' out-of-network billing and payment law (AB 72) went into effect. This law changed the billing practices of non-participating physicians providing non-emergent care at in-network facilities by requiring payors to reimburse at an interim payment rate. This law also created a dispute resolution mechanism for physicians who believe the interim payment...
The California Prostate Cancer Coalition (CPCC) and the Helen Diller Family Comprehensive Cancer Center of UC San Francisco proudly present this national conference for patients, families, caregivers, health care professionals and advocates.
California's proposed FY2020 budget includes a value-based payment incentive to providers through Medi-Cal managed care plans for meeting specific measures aimed at improving care for certain high-cost or high-need populations. The California Department of Health Care Services will discuss how they selected the proposed measures, the measure payment method, and purpose of the measures. The...
The Multinational Association of Supportive Care in Cancer joins with the International Society of Oral Oncology (ISOO) to convene the MASCC/ISOO Annual Meeting. Topics address new treatments and technologies to manage the symptoms of cancer and side effects of therapy, as well as psychosocial and economic concerns.
The Hawaii Society of Clinical Oncology and Association of Community Cancer Centers present the highlights of the 2019 ASCO Annual Meeting through its licensed ASCO Direct Highlights.
The Best of ASCO Meetings condense the most cutting-edge science and education from the world's premier oncology event, the ASCO Annual Meeting, into a two-day program. The abstracts chosen for presentation and discussion reflect the foremost research and strategies in oncology that will directly impact patient care.
The 20th Annual International Lung Cancer Congress will provide current, practical information on the management of lung cancer, as well as look at the novel agents and strategies with the potential to shape the future of lung cancer therapy. ANCO members may register for the discounted fee of $50 using code ILC19ANCO.
ANCO's ASCO Highlights 2019 will summarize the major research and treatment advancements presented at this year's ASCO Annual Meeting. The program will focus on breast, gastrointestinal, genitourinary, gynecologic, and lung cancers as well as hematologic malignancies and melanoma. The faculty will please these developments in context as to their immediate clinical utility.
“Being part of a multi-site private practice, we have a lot going on and I rely on ANCO for its fantastic education, CME opportunities and access to local experts at speaking engagements. ANCO also looks out for our best interests with its advocacy efforts and practice management tools. I look to them as a go-to local resource. There’s no question that ANCO membership is a great value for all it provides. I’m proud to be on the board and part of this thriving organization.”
Zachary Koontz, MD
Pacific Cancer Care